Cancer PainMagdi Hanna, Zbigniew (Ben) Zylicz Springer Science & Business Media, 2013 M07 31 - 286 páginas Cancer Pain provides a comprehensive, practical guide to the management of pain in cancer patients. Beginning with a discussion of current issues in the control of cancer pain, the initial chapters provide a clear, concise explanation of cancer pain syndromes, an up-to-date understanding of the pathophysiological mechanism and recent developments in creating pre-clinical cancer pain models. The book offers the reader the wide and improved options for management of cancer pain in clinical practice including the use of opioid and non-opioid drugs and the role of non-pharmacological methods in pain control. Subsequent chapters address particular challenges in pain control, such as breakthrough pain, neuropathic cancer pain, as well as pain associated with cancer treatment which, until recently, has not been fully appreciated. Recent issues relating to new adverse side effects to chronic opioid medications such as hyperalgesia and neurotoxicity are explained, and best practice to reduce or avoid them is stated. The book also aims to aid in the overall educational need for young doctors as well as established primary care physicians by highlighting the available tools and the importance of early pain interventions in the overall cancer treatment strategy. |
Contenido
2 | |
5 | |
Recent Advances in Cancer Treatment | 25 |
Pharmacogenetics of Pain in Cancer | 37 |
Mechanisms in Cancer Pain | 47 |
Preclinical Cancer Pain Models | 71 |
Pain Assessment Recognising Clinical Patterns and Cancer Pain Syndromes | 94 |
Opioids Their Receptors and Pharmacology | 109 |
New Drugs in Management of Pain in Cancer | 152 |
Neuropathic Component of Pain in Cancer | 165 |
NoncancerRelated Pain in Daily Practice | 191 |
Rehabilitation of Cancer Patients a Forgotten Need? | 203 |
Psychosocial Aspects of Cancer Pain | 211 |
Spiritual Care and Pain in Cancer | 221 |
Interventional Techniques in Cancer Pain Critical Appraisal | 230 |
Access to Opioid Analgesics Essential for Quality Cancer Care | 249 |
Critical Appraisal of the Breakthrough Pain in Cancer | 121 |
OpioidInduced Hyperalgesia | 131 |
The NonPharmacological and Local Pharmacological Methods of Pain Control | 143 |
Challenges for Pain Management in the TwentyFirst Century | 263 |
279 | |
Otras ediciones - Ver todas
Términos y frases comunes
Accessed activity acute advanced cancer afferent agonists allodynia analge analgesia analgesic animal models assessment associated bone cancer pain bone pain Bortezomib breakthrough pain breast cancer cancer patients cause celiac plexus cells chemotherapy chronic pain Clin clinical compression disease dorsal horn dose drugs efficacy factors fentanyl fibres gabapentin gene genetic hyperalgesia increased induced inhibition inhibitors injection intrathecal involved mechanisms medicines ment metastases methadone morphine muscle neurolytic neurons neuropathic pain Neurosci neurotoxicity NMDA nociceptive nociceptors Oncol opioid analgesics opioid receptors oral oxycodone paclitaxel pain control pain in cancer pain management pain models pain relief Pain Symptom Manage pain syndromes Palliat palliative pancreatic cancer pathic pain patients with cancer peripheral neuropathy Pharmacol plexopathy postoperative pregabalin prevalence protein rats rehabilitation response role sensitisation sensory side effects spinal cord spiritual stimulation tapentadol techniques therapy tion tissue tolerance tramadol treat treatment trial tumour vertebral ziconotide Zylicz